Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Clinical Drug Investigation|October 5, 2007
Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease : ACEPTO studyCarlos Martín de Argila, Julio Ponce, Emilio Márquez, et al.
Gastroenterologia Y Hepatologia|November 6, 2007
[Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease]Guillermo Bastida Paz, Pilar Nos Mateu, Mariam Aguas Peris, et al.
BMC Gastroenterology|March 4, 2010
The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patientsGuillermo Bastida, Pilar Nos, Mariam Aguas, et al.
Gut and Liver|January 19, 2017
Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?Vicente Ortiz, Diego Alvarez-Sotomayor, Esteban Sáez-González, et al.
Therapeutic Advances in Gastroenterology|February 15, 2011
Structured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trialsJulio Ponce, Vicente Garrigues, Lars Agréus, et al.
Environmental Microbiology Reports|June 13, 2013
Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndromeAna Durbán, Juan J Abellán, Nuria Jiménez-Hernández, et al.
Microbial Ecology|August 25, 2010
Assessing gut microbial diversity from feces and rectal mucosaAna Durbán, Juan J Abellán, Nuria Jiménez-Hernández, et al.
FEMS Microbiology Ecology|July 30, 2013
Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndromeAna Durbán, Juan J Abellán, Nuria Jiménez-Hernández, et al.
Inflammatory Bowel Diseases|July 29, 2009
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's diseaseBelén Beltrán, Pilar Nos, Francisco Dasí, et al.
World Journal of Gastroenterology|October 17, 2014
Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatmentCristina Sánchez-Montes, Vicente Ortiz, Guillermo Bastida, et al.
Pageof 6